The Emerging Roles of Ferroptosis in Neonatal Diseases
Wenqian Chen,Dali Zheng,Changyi Yang
DOI: https://doi.org/10.2147/JIR.S414316
IF: 4.5
2023-06-26
Journal of Inflammation Research
Abstract:Wenqian Chen, 1 Dali Zheng, 2 Changyi Yang 1 1 Department of Neonatology, Fujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, People's Republic of China; 2 Key Laboratory of Stomatology of Fujian Province, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, People's Republic of China Correspondence: Changyi Yang, Department of Neonatology, Fujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, 350001, People's Republic of China, Tel +86 15959000599, Fax +86 87279676, Email Ferroptosis is a novel type of programmed cell death involved in many diseases' pathological processes. Ferroptosis is characterized by lipid peroxidation, reactive oxygen species accumulation, and iron metabolism disorder. Newborns are susceptible to ferroptosis due to their special physiological state, which is prone to abnormal iron metabolism and the accumulation of reactive oxygen species. Recent studies have linked ferroptosis to a variety of diseases in the neonatal period (including hypoxic-ischemic encephalopathy, bronchopulmonary dysplasia, and necrotizing enterocolitis). Ferroptosis may become an effective target for the treatment of neonatal-related diseases. In this review, the ferroptosis molecular mechanism, metabolism characteristics of iron and reactive oxygen species in infants, the relationship between ferroptosis and common infant disorders, and the treatment of infant diseases targeted for ferroptosis are systematically summarized. Keywords: ferroptosis, neonatal disease, reactive oxygen species, iron metabolism, lipid peroxidation The concept of ferroptosis was first proposed by Dr. Brent R Stockwell in 2012, which is a programmed cell death mode caused by iron-dependent lipid peroxidation and reactive oxygen species accumulation. 1 Unlike other forms of cell death discovered so far, it has distinct characteristics regarding cytogenetics, biochemistry, metabolism, and morphology. A wave-like spreading pattern can be seen in its spread through cellular populations. 2 During ferroptosis, lipid peroxides (eg, malondialdehyde (MDA) and 4-hydroxynonoleic acid (4-HNE)) increase, ferroptosis-related gene changes (eg, SLC7A11, ACSL4, TFR1 up-regulated, RGS4 down-regulated) and specific changes in cell morphology (decrease in mitochondrial volume, increase in mitochondrial membrane density, decrease or disappearance of mitochondrial cristae, rupture of mitochondrial outer membrane, despite normal nucleus size, without nuclear condensation or chromatin marginalization), which is reversed by ferroptosis inhibitors like ferrostatin-1. 3 In various neonatal diseases, ferroptosis plays a significant role in the pathological process and may serve as a potential therapeutic target. 4–7 In this article, we will review ferroptosis' molecular mechanisms and its potential role in neonatal diseases. The relationship between ferroptosis and neonatal hypoxic-ischemic encephalopathy, neonatal bronchopulmonary dysplasia, and neonatal necrotizing enterocolitis was emphatically introduced. Ferroptosis is a form of programmed cell death caused by iron-dependent lipid peroxidation. Lipid peroxidation, reactive oxygen species (ROS) accumulation, and iron metabolism imbalance are the basic and central link in the molecular mechanism of ferroptosis 3 . (Figure 1, which modified from Zhang, X.2023) 8 . Figure 1 Mechanism of ferroptosis. PUFA became a part of the cell membrane under the action of ACSL4 and LPCAT3.Through the Fenton reaction and enzymatic reaction, PL-PUFA on the cell membrane undergoes a lipid peroxidation reaction to form PL-OOH. Due to the consumption of PL-PUFA and the toxic effect of peroxidation products, the cell membrane ruptures, eventually causing ferroptosis. Cystine enters the cytoplasm through System Xc- and rapidly transforms into cysteine to participate in GSH synthesis. GPX4 inhibits lipid peroxidation while reducing GSH to GSSG. Lipid peroxidation is also inhibited by FSP1 and DHODH on the cell membrane, which reduce CoQ10 to CoQ10H2. GCH1 can inhibit lipid peroxidation directly or indirectly. When the TF binds to the TFR on the cell membrane, it is endocytosed into the cell. Under the action of STEAP3 and DMT1, Fe2+ enters the cytoplasm and forms labile iron pools. Most Fe2+ is kept in ferritin. When intracellular iron is deficient, ferritin is transported to the lysosomes by NCOA4 to release Fe2+ through iron autophagy. Excess intracellular iron is excreted out of the cell through FPN1. When intracellular iron metabolism is imbalanced, the Fenton reaction and increased iron-containing enzyme activity cause ferroptosis. Note : Adapted from Zhang X, Ma Y, -Abstract Truncated-
immunology